Study tests entinostat in combination with ipilimumab and nivolumab in metastatic RCC
A single arm, phase II clinical trial for patients with metastatic renal cell carcinoma (RCC), the most common type of kidney cancer, is testing the […]
A single arm, phase II clinical trial for patients with metastatic renal cell carcinoma (RCC), the most common type of kidney cancer, is testing the […]
OncoGenex Pharmaceuticals, Inc., recently announced that Borealis-2™, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen […]
The word “advocate” comes from the Latin “ad” meaning “to” and “vocare” meaning “voice”: “to voice.” In the fight against cancer, patient advocates are those […]
Hoosier Cancer Research Network announces the appointment of Shilpa Gupta, MD, of the Cleveland Clinic, and Rana McKay, MD, of the University of California San […]
Reposted with permission by the Indiana University School of Medicine Indiana University School of Medicine physician scientist Bryan Schneider, MD is the principal investigator of […]
Neoadjuvant Pembrolizumab for Muscle-Invasive Bladder Cancer with Selective Bladder Sparing Status: Open to Accrual
Whatever each day brings, no matter how she feels at any given moment, Deneise Francis, RN, BSN, OCN, CCRP, always brings a smile and a […]
A Phase II Study of Ribociclib And Endocrine Treatment of Physician’s Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer (RaPhLRR Study) […]
Three Hoosier Cancer Research Network (HCRN) investigator-initiator clinical trials will be highlighted during the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San […]
Innovative Combination Immunotherapy for Metastatic Triple Negative Breast Cancer (TNBC): A Multicenter, Multi-Arm Translational Breast Cancer Research Consortium Study Status: Open to Accrual
The Bladder Cancer Genomics Consortium (BCGC) and Hoosier Cancer Research Network today announced the selection of Caris Life Sciences® to perform genomic profiling for UC-GENOME, […]
The Indiana University Melvin and Bren Simon Comprehensive Cancer Center, located in Indianapolis, is Indiana’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center and one […]
Hoosier Cancer Research Network (HCRN) received the Indiana Cancer Consortium (ICC) Sustained Excellence Award during the ICC’s 2021 Annual Meeting on April 21. The award […]
Noah M. Hahn, MD, deputy director of Johns Hopkins Greenberg Bladder Cancer Institute and sponsor-investigator of the multi-site Hoosier Cancer Research Network ADAPT-BLADDER study, GU16-243, […]
Researchers participating in the study known as ADAPT-BLADDER, or HCRN GU16-243, recently reported preliminary findings in the journal European Urology. The study evaluated the safety […]
The University of Alabama at Birmingham Comprehensive Cancer Center is the only National Cancer Institute-designated comprehensive cancer center located in a six-state area that includes […]
UNC Lineberger Comprehensive Cancer Center is a cancer research and treatment center at the University of North Carolina at Chapel Hill. Serving patients at the […]
UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty […]
Georgetown Lombardi Comprehensive Cancer Center is designated by the National Cancer Institute (NCI) as a comprehensive cancer center. A part of Georgetown University Medical Center, […]
First established at Northwestern University in 1974, the center was dedicated as the Robert H. Lurie Cancer Center of Northwestern University in 1991 through a […]
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter